HansBiomed Corporation (KOSDAQ:042520)

HansBiomed Statistics

Total Valuation

HansBiomed has a market cap or net worth of KRW 112.21 billion. The enterprise value is 143.56 billion.

Market Cap	112.21B
Enterprise Value	143.56B

Important Dates

The next estimated earnings date is Wednesday, August 13, 2025.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

HansBiomed has 12.99 million shares outstanding. The number of shares has increased by 7.33% in one year.

Current Share Class	12.99M
Shares Outstanding	12.99M
Shares Change (YoY)	+7.33%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	26.95%
Owned by Institutions (%)	0.67%
Float	7.06M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.33
PB Ratio	1.72
P/TBV Ratio	1.74
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 73.14, with an EV/FCF ratio of -52.17.

EV / Earnings	-21.68
EV / Sales	1.70
EV / EBITDA	73.14
EV / EBIT	n/a
EV / FCF	-52.17

Financial Position

The company has a current ratio of 1.08, with a Debt / Equity ratio of 0.66.

Current Ratio	1.08
Quick Ratio	0.50
Debt / Equity	0.66
Debt / EBITDA	7.33
Debt / FCF	-15.70
Interest Coverage	0.34

Financial Efficiency

Return on equity (ROE) is -10.22% and return on invested capital (ROIC) is 0.36%.

Return on Equity (ROE)	-10.22%
Return on Assets (ROA)	0.31%
Return on Invested Capital (ROIC)	0.36%
Return on Capital Employed (ROCE)	0.82%
Revenue Per Employee	320.74M
Profits Per Employee	-25.18M
Employee Count	263
Asset Turnover	0.68
Inventory Turnover	1.19

Taxes

In the past 12 months, HansBiomed has paid 1.67 billion in taxes.

Income Tax	1.67B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -15.95% in the last 52 weeks. The beta is 0.84, so HansBiomed's price volatility has been lower than the market average.

Beta (5Y)	0.84
52-Week Price Change	-15.95%
50-Day Moving Average	8,811.20
200-Day Moving Average	8,150.30
Relative Strength Index (RSI)	51.70
Average Volume (20 Days)	24,855

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HansBiomed had revenue of KRW 84.36 billion and -6.62 billion in losses. Loss per share was -510.64.

Revenue	84.36B
Gross Profit	52.56B
Operating Income	612.84M
Pretax Income	-5.37B
Net Income	-6.62B
EBITDA	5.89B
EBIT	612.84M
Loss Per Share	-510.64

Balance Sheet

The company has 11.75 billion in cash and 43.19 billion in debt, giving a net cash position of -31.45 billion or -2,421.46 per share.

Cash & Cash Equivalents	11.75B
Total Debt	43.19B
Net Cash	-31.45B
Net Cash Per Share	-2,421.46
Equity (Book Value)	65.21B
Book Value Per Share	5,028.31
Working Capital	4.54B

Cash Flow

In the last 12 months, operating cash flow was -553.02 million and capital expenditures -2.20 billion, giving a free cash flow of -2.75 billion.

Operating Cash Flow	-553.02M
Capital Expenditures	-2.20B
Free Cash Flow	-2.75B
FCF Per Share	-211.91

Margins

Gross margin is 62.30%, with operating and profit margins of 0.73% and -7.85%.

Gross Margin	62.30%
Operating Margin	0.73%
Pretax Margin	-6.36%
Profit Margin	-7.85%
EBITDA Margin	6.98%
EBIT Margin	0.73%
FCF Margin	n/a

Dividends & Yields

HansBiomed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.33%
Shareholder Yield	n/a
Earnings Yield	-5.90%
FCF Yield	-2.45%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HansBiomed has an Altman Z-Score of 1.78 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.78
Piotroski F-Score	5